Rising Prevalence Of Contagious Respiratory Illnesses Drives Influenza Treatment Market Growth: Key Factor Driving The Growth In The Influenza Treatment Market

The Influenza Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Influenza Treatment Market Size During the Forecast Period?
The influenza treatment market size has grown steadily in recent years. It will grow from $6.6 billion in 2024 to $6.9 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to a growth in the number of annual influenza cases, increased government funding for influenza research and preparedness programs, public awareness campaigns promoting vaccination, the establishment of global influenza surveillance systems, and growth in healthcare facilities.

The influenza treatment market is set to witness steady growth in the next few years, expected to reach $8.16 billion by 2029 at a CAGR of 4.3%. This growth is driven by the introduction of new antiviral drugs and treatment options, expanding vaccination programs, the continuous improvement of healthcare infrastructure, an aging population, and the development of new treatments. Key trends include advancements towards developing universal vaccines, innovations in vaccine delivery systems, the integration of AI and big data, breakthroughs in personalized medicine, and increasing collaborations between pharmaceutical companies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15832

What Are the High-Growth Segments in the Influenza Treatment Market?
The influenza treatment market covered in this report is segmented -

1) By Product Type: Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products
2) By Route Of Administration: Oral, Other Routes Of Administration
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels

Subsegments:
1) By Peramivir: Intravenous Peramivir, Peramivir Injection
2) By Zanamivir: Inhaled Zanamivir, Zanamivir Diskhaler
3) By Oseltamivir Phosphate: Oseltamivir Capsules, Oseltamivir Oral Suspension
4) By Baloxavir Marboxil: Baloxavir Tablets, Baloxavir Granules For Oral Suspension
5) Other Products: Rimantadine, Amantadine

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15832&type=smp

What Key Drivers Are Expected to Influence Future Influenza Treatment Market Growth?
The growing rate of contagious respiratory diseases is projected to boost the influenza treatment market. Contagious respiratory diseases like the flu, RSV, and measles spread through person-to-person contact, contaminated surfaces, or bodily fluids. This rise is driven by high population density, international travel, and limited healthcare access. Influenza treatment typically involves antivirals and vaccines to combat various respiratory viruses, including the flu and COVID-19. According to the CDC in September 2023, RSV-related hospitalization rates rose from 2 per 100,000 people during the week ending August 5 to 7 per 100,000 by the week ending August 19. Thus, increasing respiratory illness rates are advancing the influenza treatment market.

Which Companies Hold the Largest Share Across Different Influenza Treatment Market Segments?
Major companies operating in the influenza treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Fujifilm Holdings Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited., Chugai Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, NATCO Pharma Limited, BioCryst Pharmaceuticals Inc., NanoViricides Inc.

What Are the Major Trends Shaping the Influenza Treatment Market?
Leading businesses in the influenza treatment market are looking to broaden their product range with fresh and innovative solutions, such as a single-dose oral treatment for influenza. This addition aims to increase patient adherence, enhance therapeutic outcomes, and secure a bigger share of the market. A single-dose oral drug is one that's designed to treat influenza (flu) with just one oral dose, streamlining the treatment process. For example, in August 2022, Genentech Inc., a biotech company from the US, announced that FDA had approved Xofluza (Baloxavir Marboxil). Xofluza is the only single-dose oral therapy that offers a straightforward and effective answer for managing acute uncomplicated influenza in children aged five to less than 12 years, who have shown symptoms for less than 48 hours, and other respiratory viruses.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

What Are the Emerging Geographies for The Influenza Treatment Market Growth?
North America was the largest region in the influenza treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Influenza Treatment Market?
2. What is the CAGR expected in the Influenza Treatment Market?
3. What Are the Key Innovations Transforming the Influenza Treatment Industry?
4. Which Region Is Leading the Influenza Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.